Biotech

All Articles

Rivus' period 2 obesity-related cardiac arrest test hits endpoint

.Rivus Pharmaceuticals has actually plumped up the potential customers of its own fat-busting, muscl...

Ovid halts preclinical job, IV plan after soticlestat neglect

.Ovid Therapy actually disclosed final month that it was trimming back its headcount as the firm bro...

Eli Lilly opens $700M nucleic acid R&ampD facility in Boston ma Seaport

.Eli Lilly has actually opened a $700 thousand R&ampD facility in the Boston Seaport, boosting its o...

Boundless Biography helps make 'modest' discharges five months after $100M IPO

.Just five months after getting a $one hundred million IPO, Boundless Biography is actually already ...

Halda's $126M will evolve 'secure and kill' cyst drugs

.The first stages of oncology R&ampD may not be short of intriguing brand new techniques, and also H...

Lykos 'disappointments' certainly not making known research study transgressions with author

.Psychopharmacology has drawn three articles regarding midstage professional test information determ...

Analysts go into Avidity's DMD gain, exposing nuances in records

.Avidity Biosciences satisfied financiers with stage 1/2 information in Duchenne muscle dystrophy (D...

Actinogen's cortisol blocker neglects period 2 depression research

.Actinogen Medical's cortisol blocker has overlooked the key endpoint of a period 2 research in clin...

Bivictrix makes a decision going exclusive only means to take ADC right into medical clinic

.Antibody-drug conjugates (ADCs) have actually gone to the center of a lot of a billion-dollar biobu...

TPG tops up funds to $580M for financial investments all over lifestyle sciences

.Asset supervisor TPG, which has actually supported biotechs such as Sionna Rehabs and also Santa Cl...